Jeffrey R Schelling
Overview
Explore the profile of Jeffrey R Schelling including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
76
Citations
2961
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Peschard V, Scherzer R, Estrella M, Sarnak M, Ascher S, Lash J, et al.
Clin J Am Soc Nephrol
. 2025 Mar;
PMID: 40085155
Background: Individual kidney tubule biomarkers are associated with risks for chronic kidney disease (CKD) progression and mortality in persons with diabetes. Integrating multiple kidney biomarkers using a latent variable method...
2.
Khan S, Gaivin R, Liu Z, Li V, Samuels I, Son J, et al.
bioRxiv
. 2025 Feb;
PMID: 39975070
Graphical Abstract:
3.
Greenberg J, Abraham A, Xu Y, Schelling J, Coca S, Schrauben S, et al.
J Am Soc Nephrol
. 2025 Jan;
PMID: 39820177
No abstract available.
4.
Porta D, Carrillo M, Perez H, Rivoira M, Ledesma G, Munoz S, et al.
J Nephrol
. 2024 Nov;
38(1):207-214.
PMID: 39579328
Background: Chronic kidney disease (CKD) increases cardiovascular risk, however, traditional cardiovascular risk factors cannot entirely explain it. A real-world investigation examined the concept that renal function decline is linked to...
5.
Amatruda J, Katz R, Rebholz C, Sarnak M, Gutierrez O, Schrauben S, et al.
Kidney Med
. 2024 Jun;
6(6):100834.
PMID: 38826568
Rationale & Objective: Tubulointerstitial damage is a feature of early chronic kidney disease (CKD), but current clinical tests capture it poorly. Urine biomarkers of tubulointerstitial health may identify risk of...
6.
Dobre M, Ahlawat S, Schelling J
Curr Opin Nephrol Hypertens
. 2024 Jan;
33(2):203-211.
PMID: 38193308
Purpose Of Review: Cardiomyopathy in chronic kidney disease (CKD) is a complex condition with multiple triggers and poor prognosis. This review provides an overview of recent advances in CKD-associated cardiomyopathy,...
7.
Ren Y, Ruan P, Segal M, Dobre M, Schelling J, Banerjee U, et al.
PLoS One
. 2023 Dec;
18(12):e0293945.
PMID: 38079395
Background: Patients with kidney failure suffer high mortality, and we currently lack markers for risk stratification for these patients. We carried out a quality control study of a modified aptamer...
8.
Le D, Chen J, Shlipak M, Ix J, Sarnak M, Gutierrez O, et al.
Kidney Med
. 2023 Oct;
5(11):100719.
PMID: 37841418
Rationale & Objective: Biomarkers of kidney disease progression have been identified in individuals with diabetes and underlying chronic kidney disease (CKD). Whether or not these markers are associated with the...
9.
Kumar M, Gaivin R, Khan S, Fedorov Y, Adams D, Zhao W, et al.
Int J Biol Macromol
. 2023 Jun;
244:125328.
PMID: 37307967
Diabetes is a major public health problem due to morbidity and mortality associated with end organ complications. Uptake of fatty acids by Fatty Acid Transport Protein-2 (FATP2) contributes to hyperglycemia,...
10.
Jiang K, Greenberg J, Abraham A, Xu Y, Schelling J, Feldman H, et al.
Kidney360
. 2023 Jun;
4(8):1039-1047.
PMID: 37303083
No abstract available.